Addressing Vaccine Hesitancy in the Age of COVID-19.

Allison Fisher, Sarah Mbaeyi, Amanda Cohn
Author Information
  1. Allison Fisher: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga. Electronic address: amfisher@cdc.gov.
  2. Sarah Mbaeyi: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.
  3. Amanda Cohn: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.

Abstract

No abstract text available.

References

  1. Pediatrics. 2013 Dec;132(6):1037-46 [PMID: 24190677]
  2. MMWR Morb Mortal Wkly Rep. 2019 May 03;68(17):402-404 [PMID: 31048672]
  3. Am J Prev Med. 2015 Dec;49(6 Suppl 4):S426-34 [PMID: 26297448]
  4. Pediatrics. 2020 Jul;146(1): [PMID: 32540985]
  5. MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1505-1511 [PMID: 33090985]
  6. Vaccine. 2015 Nov 27;33 Suppl 4:D66-71 [PMID: 26615171]
  7. J Pediatr. 2013 Aug;163(2):561-7 [PMID: 23545349]
  8. MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):75-82 [PMID: 33476312]

MeSH Term

Adult
COVID-19
COVID-19 Vaccines
Child
Humans
Pandemics
United States
Vaccination
Vaccination Refusal

Chemicals

COVID-19 Vaccines

Word Cloud

Created with Highcharts 10.0.0AddressingVaccineHesitancyAgeCOVID-19

Similar Articles

Cited By